JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB133633

Anti-CEACAM5 抗体 [EPCEAR7]

Anti-CEACAM5 antibody [EPCEAR7]

  • BOND RX™ Validated
  • KO Validated
  • RabMAb
  • Recombinant
  • 20ul selling size
  • 了解详情

Be the first to review this product! Submit a review

|

(20 Publications)

Anti-Carcino Embryonic Antigen CEA antibody [EPCEAR7] (ab133633) is a rabbit monoclonal antibody detecting CEACAM5 in Western Blot, IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications

查看别名

CD66e, CEA, CEACAM5, Cell adhesion molecule CEACAM5, Carcinoembryonic antigen, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100, CEA cell adhesion molecule 5

17 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human gastric carcinoma tissue sections labeling Carcino Embryonic Antigen CEA with Purified ab133633 at 1 : 3000 dilution (0.6 μg/ml). Heat mediated antigen retrieval was performed using Perform heat mediated antigen retrieval using EDTA Buffer, PH9. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human colon tissue sections labeling Carcino Embryonic Antigen CEA with Purified ab133633 at 1 : 3000 dilution (0.6 μg/ml). Heat mediated antigen retrieval was performed using Perform heat mediated antigen retrieval using EDTA Buffer, PH9. Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

ab133633 showing negative staining in Hepatocellular carcinoma tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Immunohistochemistry analysis of paraffin-embedded (A) HEK-293T cells transfected with a CEACAM1 expression vector containing a his tag, (B) HEK-293T cells transfected with a CEACAM3 expression vector containing a his tag, (C) HEK-293T cells transfected with a CEACAM5 expression vector containing a his tag, (D) HEK-293T cells transfected with a CEACAM6 expression vector containing a his tag, (E) HEK-293T cells transfected with a CEACAM8 expression vector containing a his tag and (F) HEK-293T cells transfected with empty vector containing a his tag, sections labelling Carcino Embryonic Antigen CEA with ab133633 at 1/2000 dilution. LeicaDS9800 (Bond™ Polymer Refine Detection) was used as the secondary antibody. Sections were counterstained with Hematoxylin. The section was incubated with ab133633 for 30 mins at room temperature. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins. Positive staining on HEK-293T cells transfected with a CEACAM5 expression vector containing a his tag (Image C), and HEK-293T cells transfected with a CEACAM6 expression vector containing a his tag (Image D). No staining on other cell pellet tested. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. IHC Note : ab133633 is also cross-reactIve with human CEACAM6 in IHC.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Immunohistochemical analysis of paraffin embedded Human colon carcinoma tissue labelling Carcino Embryonic Antigen CEA with ab133633 at 1/250.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

ab133633 showing negative staining in Normal tonsil tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

ab133633 showing positive staining in Stomach adenocarcinoma tissue.

Immunocytochemistry/ Immunofluorescence - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Confocal image showing membranous staining in MCF7 cell line.

Immunocytochemistry/Immunofluorescence analysis of MCF7 (human breast adenocarcinoma cell line) cells labelling carcino embryonic antigen (CEA) with ab133633 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (ab150077) at 1/10000 dilution was used as the secondary antibody. The cells were counterstained with ab195889, a anti-alpha tubulin antibody at 1/200 dilution. DAPI was used as a nuclear counterstain.

Secondary antibody only control : Used PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • WB

Lab

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Exposure time : Lane 1 : 10 seconds; Lane 2 : 180 seconds

We recommend not to boil the sample after lysis to get desirable WB result.

All lanes:

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (ab133633)

Lane 1:

Human colon tissue lysate unboiled at 20 µg

Lane 2:

Human colon tissue lysate boiled at 20 µg

Observed band size: 180-200 kDa

false

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • WB

Lab

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Western blot : Anti-CEACAM5 antibody [EPCEAR7] (ab133633) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab133633 was shown to bind specifically to CEACAM5. A band was observed at 160-180 kDa in wild-type A549 cell lysates with no signal observed at this size in CEACAM5 knockout cell line. To generate this image, wild-type and CEACAM5 knockout A549 unboiled cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (ab133633) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

CEACAM5 knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human CEACAM5 knockout A549 cell line (ab287319)

Lane 3:

MCF7 (unboiled) cell lysate at 20 µg

Lane 4:

PANC-1 (unboiled) cell lysate at 20 µg

Observed band size: 160-180 kDa

true

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • WB

Supplier Data

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Blocking buffer and concentration :  5% NFDM/TBST.  Diluting buffer and concentration :  5% NFDM/TBST. ab181602 was used as a loading control. We recommend not to boil the sample after lysis to get desirable WB result.

All lanes:

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (ab133633) at 1/1000 dilution

Lane 1:

BxPC-3 (Human pancreas adenocarcinoma epithelial cell) whole cell lysate boiled at 20 µg

Lane 2:

BxPC-3 (Human pancreas adenocarcinoma epithelial cell) whole cell lysate unboiled at 20 µg

Lane 3:

MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate boiled at 20 µg

Lane 4:

MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate unboiled at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 76 kDa

Observed band size: 180-200 kDa

false

Exposure time: 3s

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • WB

Unknown

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

All lanes:

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (ab133633) at 1/1000 dilution

All lanes:

Human colon cancer lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution

Predicted band size: 76 kDa

Observed band size: 180-200 kDa

false

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • WB

Unknown

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (ab133633) at 0.4 µg/mL

All lanes:

Human colon cancer lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 76 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

ab133633 showing negative staining in Skeletal muscle tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

ab133633 showing negative staining in Thyroid gland carcinoma tissue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

ab133633 showing negative staining in Glioma tissue.

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)
  • WB

Lab

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (AB133633)

Blocking and diluting buffer and concentration : 5% NFDM/TBST

This antibody does not cross-react with human CEACAM1, CEACAM3, CEACAM6, and CEACAM8.

This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

All lanes:

Western blot - Anti-CEACAM5 antibody [EPCEAR7] (ab133633) at 1/1000 dilution

Lane 1:

His-tagged human CEACAM1 recombinant protein (aa 35-428) at 0.02 µg

Lane 2:

His-tagged human CEACAM3 recombinant protein (aa 35-252) at 0.02 µg

Lane 3:

His-tagged human CEACAM5 recombinant protein (aa 35-586) at 0.02 µg

Lane 4:

His-tagged human CEACAM6 recombinant protein (aa 35-320) at 0.02 µg

Lane 5:

His-tagged human CEACAM8 recombinant protein (aa 35-320) at 0.02 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 76 kDa

Observed band size: 180 kDa

true

Exposure time: 3min

不同偶联物与剂型 (2)

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPCEAR7

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

ICC/IF, IHC-P, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p>We recommend not to boil the sample after lysis to get desirable WB result.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/500", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000 - 1/3000", "IHCP-species-notes": "<p><strong>For unpurified use at 1/250 - 1/500.</strong></p><p>ab133633 is also cross-reactIve with human CEACAM6 in IHC.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Recombinant full length protein - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Transfected cell line - Human": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000 - 1/3000", "IHCP-species-notes": "<p><strong>For unpurified use at 1/250 - 1/500.</strong></p><p>ab133633 is also cross-reactIve with human CEACAM6 in IHC.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

产品详情

What is this antibody validated in?
Anti-Carcino Embryonic Antigen CEA antibody [EPCEAR7] (ab133633) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of CEACAM5?
Anti-Carcino Embryonic Antigen CEA [EPCEAR7] (ab133633) specifically detects a band for CEACAM5 (UniProt: P06731) at a molecular weight of 76kDa.

Trusted by the scientific community
Anti-Carcino Embryonic Antigen CEA [EPCEAR7] (ab133633) was first used in a scientific publication in 2012 and has been cited over 10 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-Carcino Embryonic Antigen CEA antibody [EPCEAR7] (ab133633) has been confirmed by Western blot testing in CEACAM5 Knockout A549 cells.

Other related products
We have a range of other formats of antibody clone [EPCEAR7] also available for your convenience: ab133633, Alexa Fluor® 488 - ab214868, Carrier free - ab226144

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle|Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

CEACAM5 also known as Carcinoembryonic Antigen (CEA) or CD66e is a glycoprotein found mainly on the surface of epithelial cells. This protein has a mass of approximately 180 kDa. It gets expressed in a variety of tissues with high expression in the gastrointestinal tract including the colon and rectum. CEACAM5 is a member of the immunoglobulin superfamily and plays a role in cell adhesion influencing how cells stick to each other.
Biological function summary

CEACAM5 contributes to cellular processes involving cell adhesion and immune response modulation. This protein operates as part of a larger group of cell adhesion molecules and does not function as part of a complex. CEACAM5 can affect the interactions between cells and the extracellular matrix which has implications for tissue structuring and integrity. It helps the immune system recognize and respond to infectious agents or cellular anomalies.

Pathways

CEACAM5 involvement extends to immune response regulation and cell adhesion pathways. It interacts functionally with proteins like E-cadherin in these pathways which contribute to maintaining epithelial integrity. These pathways are critical for normal tissue maintenance and immune system function especially in mucosal surfaces where pathogen entry occurs. Understanding CEACAM5 interactions provides insight into cellular communication and adhesion mechanisms.

CEACAM5 is associated with colorectal cancer and lung adenocarcinoma. Its overexpression and release into the bloodstream make it a popular biomarker for these diseases. CEACAM5 is used in clinical applications such as CEA ELISA assays for cancer detection and monitoring. In colorectal cancer CEACAM5 interacts with proteins like CEACAM6 to promote tumor invasiveness and metastasis. Anti-CEACAM5 therapeutics including antibody-drug conjugates (anti-CEACAM5 ADC) are being developed to target and treat associated malignancies.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed : 10864933, PubMed : 10910050, PubMed : 2803308). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed : 2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed : 10910050).. (Microbial infection) Receptor for E.coli Dr adhesins. Binding of E.coli Dr adhesins leads to dissociation of the homodimer.
See full target information CEACAM5

文献 (20)

Recent publications for all applications. Explore the full list and refine your search

Materials today. Bio 32:101768 PubMed40290895

2025

A microfluidic electrochemical immunosensor for detection of CEA and Ki67 in 3D tumor spheroids.

Applications

Unspecified application

Species

Unspecified reactive species

Sujin Kim,Seonyeop Kim,Chanjin Ko,Wonseok Lee,Hwan Drew Kim

SAGE open medical case reports 12:2050313X241261152 PubMed38887262

2024

Allergic hyper-carcinoembryonic antigen syndrome: A syndrome summarized by case series.

Applications

Unspecified application

Species

Unspecified reactive species

Zhaolin Li,Luna Hong,Yuewei Li,Xiaoling Lin,Ming Chen,Shiyi Bu,Shuwan Xu,Qiaojun Zeng,Yijiao Huang,Lijuan Bian,Jianming Zheng,Boying Gao,Guirong Liu,Wenman He,Xueming Song,Fengzhan Ye,Linjie Huang,Shanping Jiang,Jianting Shi,Tiantian Tang

The Journal of dermatology 51:e160-e161 PubMed38009840

2023

A case of acquired idiopathic generalized anhidrosis with perspiration maintained at sites of brodalumab injection to treat psoriasis vulgaris.

Applications

Unspecified application

Species

Unspecified reactive species

Asuka Mikoshiba,Shiho Katsuie,Kosuke Satake,Shoya Kitamura,Yuki Sato,Yukiko Kiniwa,Kenji Sano,Ryuhei Okuyama

Signal transduction and targeted therapy 8:399 PubMed37857598

2023

Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Wang,Jingyi Han,Dongdong Wang,Menghua Cai,Yi Xu,Yu Hu,Hui Chen,Wei He,Jianmin Zhang

Cancers 15: PubMed37686514

2023

Enhanced Therapeutic Effects of Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts.

Applications

Unspecified application

Species

Unspecified reactive species

Tabassom Mohajershojai,Douglas Spangler,Saloni Chopra,Fredrik Y Frejd,Paul J Yazaki,Marika Nestor

Transgenic research 32:305-319 PubMed37247123

2023

The potential oncogenic effect of tissue-specific expression of JC polyoma T antigen in digestive epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hua-Chuan Zheng,Hang Xue,Hong-Zhi Sun,Wen-Jing Yun,Zheng-Guo Cui

EBioMedicine 89:104476 PubMed36801616

2023

NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoyong Guo,Changjian Li,Xiaohua Jia,Yawei Qu,Miaomiao Li,Caiguang Cao,Zeyu Zhang,Qiaojun Qu,Shuangling Luo,Jianqiang Tang,Haifeng Liu,Zhenhua Hu,Jie Tian

Bio-protocol 13: PubMed36789090

2023

Safety Profiling of Tumor-targeted T Cell-Bispecific Antibodies with Alveolus Lung- and Colon-on-Chip.

Applications

Unspecified application

Species

Unspecified reactive species

Jordan S Kerns,Chaitra Belgur,Marianne Kanellias,Dimitris V Manatakis,Riccardo Barrile,Will Tien-Street,Lorna Ewart,Nikolche Gjorevski,Lauriane Cabon

Frontiers in oncology 12:1043479 PubMed36591461

2022

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models.

Applications

Unspecified application

Species

Unspecified reactive species

Dengxu Tan,Jiaze An,Miaomiao Gong,Huihui Wang,Han Li,Han Meng,Caiqin Zhang,Yong Zhao,Xu Ge,Changhong Shi

Translational oncology 24:101491 PubMed35882167

2022

CEACAM5 targeted by miR-498 promotes cell proliferation, migration and epithelial to mesenchymal transition in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Zhang,Chao Zhang,Nian Liu
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com